# Impact of Fingolimod Adherence on Outcomes

> **NCT05141669** · — · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 694 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Fingolimod

## Key facts

- **NCT ID:** NCT05141669
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-18
- **Primary completion:** 2020-11-20
- **Final completion:** 2020-11-20
- **Target enrollment:** 694 (ACTUAL)
- **Last updated:** 2021-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05141669

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05141669, "Impact of Fingolimod Adherence on Outcomes". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05141669. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*